NCT00092911已完成3 期
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy And Safety Study of a Flexible Dose of DVS-233 SR in Adult Outpatients With Major Depressive Disorder
Wyeth is now a wholly owned subsidiary of Pfizer0 个研究点目标入组 244 人开始时间: 2004年9月28日最近更新:
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 244
研究概览
简要总结
The main objective of this study is to compare the antidepressant efficacy and safety of DVS-233 SR versus placebo in adult outpatients with Major Depressive Disorder.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Outpatients
- •Men and women age 18 years of age and older
- •Women of childbearing potential participating in the study must have a negative serum pregnancy test result at screening and use a medically acceptable form of contraception
排除标准
- •Treatment with DVS-233 SR at any time in the past
- •Treatment with venlafaxine (immediate release [IR] or extended release [ER]) within 90 days of study day 1
- •Known hypersensitivity to venlafaxine (IR or ER)
- •Significant risk of suicide based on clinical judgment, including common
研究者
相似试验
已完成
3 期
Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive DisorderMajor Depressive DisorderNCT00073762Wyeth is now a wholly owned subsidiary of Pfizer375
已完成
3 期
Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive DisorderMajor Depressive DisorderNCT00072774Wyeth is now a wholly owned subsidiary of Pfizer480
已完成
3 期
Study Evaluating the Efficacy and Safety of Desvenlafaxine Tablets in Adult Outpatients With Major Depressive DisorderDepressive Disorder, MajorNCT00300378Wyeth is now a wholly owned subsidiary of Pfizer480
已完成
3 期
Study Evaluating DVS-233 in Adult Outpatients With Major Depressive DisorderMajor Depressive DisorderNCT00063206Wyeth is now a wholly owned subsidiary of Pfizer247
已完成
3 期
Study Evaluating DVS-233 SR And Venlafaxine ER In Adult Outpatients With Major Depressive DisorderMajor Depressive DisorderNCT00090649Wyeth is now a wholly owned subsidiary of Pfizer369